Search | IOVS | ARVO Journals

View

Showing 1 – 14 of 14

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

Examination of the effect of topical aqueous suppressants on the efficacy of anti-VEGF infections for age-related macular degeneration

Jonathan Minkowski; Mathew MacCumber

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):832. doi:

ARVO Annual Meeting Abstract July 2018

Optical Coherence Tomography Features as Pre-operative predictors of Post-operative Visual Improvement in Patients Undergoing Epiretinal Membrane and Internal Limiting Membrane Peeling

John Charles Zeyer; Paul R Parker; Mathew MacCumber

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1099. doi:

ARVO Annual Meeting Abstract June 2017

The Real World Effect of Anti-VEGF Injections on IOP Using the IRIS Registry

Elizabeth Anne Atchison; Catherine N Barry; Flora Lum; Cynthia Mattox; Mathew W MacCumber

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):871. doi:

ARVO Annual Meeting Abstract June 2017

ORBIT: A Phase IV Clinical Study – Efficacy and Safety Outcomes From Ocriplasmin Intravitreal Injection

Brian C Joondeph; Arshad M Khanani; Jay S Duker; David S Boyer; Jeffrey Heier; Peter K Kaiser; Mathew W MacCumber; Dante Joseph Pieramici

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3703. doi:

ARVO Annual Meeting Abstract September 2016

ORBIT: A phase IV clinical study - lessons learned from patient selection criteria for ocriplasmin intravitreal injection

Brian C Joondeph; Jay S Duker; David S Boyer; Jeffrey S Heier; Peter K Kaiser; Mathew W MacCumber; Dante Joseph Pieramici

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4063. doi:

ARVO Annual Meeting Abstract September 2016

Visual Results and Complications of Surgery for Dislocated Intraocular Lens

Eileen Tonner; Mathew W MacCumber

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4468. doi:

ARVO Annual Meeting Abstract June 2015

Six-Month Results From the ORBIT Study: Ocriplasmin Research to Better Inform Treatment of Symptomatic Vitreomacular Adhesion

Jay S Duker; David S Boyer; Jeffrey S Heier; Peter K Kaiser; Mathew W MacCumber; Dante Joseph Pieramici

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1203. doi:

ARVO Annual Meeting Abstract June 2015

Outcomes following surgical management of atypical macular holes

Alexander Grigalunas; Fatma Dihowm; Mario Moric; Mathew W MacCumber

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5075. doi:

ARVO Annual Meeting Abstract April 2014

Impact of Concomitant Aqueous Suppressants on PRN Treatment with Ranibizumab in the 24 Month HARBOR Study

Mathew MacCumber; Howard Shapiro; Lisa Tuomi

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3967. doi:

ARVO Annual Meeting Abstract June 2013

A Comparison of Two Commercially Available Genetic Tests for Age-Related Macular Degeneration

Nancy Holekamp; Mathew MacCumber; Arghavan Almony

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3374. doi:

ARVO Annual Meeting Abstract June 2013

Comparison of outcomes between 20, 23 and 25 gauge vitrectomy for idiopathic macular hole

Fatma Dihowm; Mathew MacCumber

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):2806. doi:

ARVO Annual Meeting Abstract June 2013

Intravitreal Bevacizumab for Post-Operative Vitreous Hemorrhage After Vitrectomy for Diabetic Retinopathy

Kevin Ferenchak; Renaud Duval; Jack Cohen; Mathew MacCumber

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):208. doi:

ARVO Annual Meeting Abstract April 2011

Scleral Buckling Surgery for Rhegmatogenous Retinal Detachment

Anna Gabrielian; Jack A. Cohen; Joseph M. Civantos; John S. Pollack; Mathew M. MacCumber; Pauline T. Merrill; Sohail J. Hasan; Zac B. Ravage; Kirk H. Packo; Kourous Rezaei

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):6164. doi:

ARVO Annual Meeting Abstract April 2011

Ranibizumab for the Treatment of Persistent Diabetic Retinal Neovascularization as Assessed by Super Wide-Field Angiography (Optos)

Ryan Basham; Anna Gabrielian; Mathew W. MacCumber

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1297. doi:

Advertisement